The Dual Role of the Kidney in Primary Aldosteronism: Key Determinant in Rescue From Volume Expansion and Persistence of Hypertension

American Journal of Kidney Diseases

Volumn 54, Issue 4, 2009, Pages 594-597

  Sechi, Leonardo A ^a   Catena, Cristiana ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALECTOMY; BODY MASS; DISEASE COURSE; EDITORIAL; GLOMERULUS FILTRATION RATE; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIMARY HYPERALDOSTERONISM; RETROSPECTIVE STUDY; URINARY EXCRETION;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ALDOSTERONE; BLOOD PRESSURE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; KIDNEY;

EID: 70349260701     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.08.004     Document Type: Editorial

References (31)

1. Stowasser M., Gordon R.D., Gunasekera T.G., et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after "non-selective" screening of hypertensive patients. J Hypertens 21 11 (2003) 2149-2157
2. Funder J.W., Carey R.M., Fardella C., et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93 9 (2008) 3266-3281
3. Letavernier E., Peyrard S., Amar L., Zinzindohoue F., Fiquet B., and Plouin P.F. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 26 9 (2008) 1816-1823
4. Blumenfeld J.D., Sealey J.E., Schlussel Y., et al. Diagnosis and treatment of primary aldosteronism. Ann Intern Med 121 11 (1994) 877-885
5. Sawka A.M., Young W.F., Thompson G.B., et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 135 4 (2001) 258-261
6. Catena C., Colussi G.L., Lapenna R., et al. Long-term cardiac effects of adrenalectomy in patients with primary aldosteronism. Hypertension 50 5 (2007) 911-918
7. Obara T., Ito Y., Okamoto T., et al. Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism. Surgery 112 6 (1992) 987-993
8. Stowasser M., Klemm S.A., Tunny T.J., Storie W.J., Rutherford J.C., and Gordon R.D. Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness. Clin Exp Pharmacol Physiol 21 4 (1994) 319-322
9. Celen O., O'Brien M.J., Melby J.C., and Beazley R.M. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 131 6 (1996) 646-650
10. Lo C.Y., Tam P.C., Kung A.W., Lam K.S., and Wong J. Primary aldosteronism: results of surgical treatment. Ann Surg 224 2 (1996) 125-130
11. Proye C.A., Mulliez E.A., Carnaille B.M., et al. Essential hypertension: first reason for persistent hypertension after unilateral adrenalectomy for primary aldosteronism?. Surgery 124 6 (1998) 1128-1133
12. Horita Y., Inenaga T., Nakahama H., et al. Cause of residual hypertension after adrenalectomy in patients with primary aldosteronism. Am J Kidney Dis 37 5 (2001) 884-889
13. Meria P., Kempf B.F., Hermieu J.F., Plouin P.F., and Duclos J. Laparoscopic management of primary aldosteronism: clinical experience with 212 cases. J Urol 169 1 (2003) 32-35
14. Lumachi F., Ermani M., Basso S.M., Armanini D., Iacobone M., and Favia G. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 71 10 (2005) 864-869
15. Wu V.-C., Chueh S.-C., Chang H.-W., et al. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 54 4 (2009) 665-673
16. Hollenberg N.K. Aldosterone in the development and progression of renal injury. Kidney Int 66 1 (2004) 1-9
17. Beevers D.G., Brown J.J., Ferriss J.B., et al. Renal abnormalities and vascular complications in primary aldosteronism: evidence of tertiary hyperaldosteronism. Q J Med 45 175 (1976) 401-410
18. Danforth Jr. D.N., Orlando M.M., Bartter F.C., and Javadpour N. Renal changes in primary aldosteronism. J Urol 117 2 (1977) 140-144
19. Bravo E.L., Fouad-Tarazi F.M., Tarazi R.C., Pohl M., Gifford R.W., and Vidt D.G. Clinical implications of primary aldosteronism with resistant hypertension. Hypertension 11 2, pt 2 (1988) 207-211
20. Nishimura M., Uzu T., Fujii T., et al. Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 33 2 (1999) 262-266
21. Rossi G.P., Bernini G., Desideri G., et al. Renal damage in primary aldosteronism: results of the PAPY study. Hypertension 48 2 (2006) 232-238
22. Catena C., Colussi G.L., Nadalini E., et al. Relationships of plasma renin levels with renal function in patients with primary aldosteronism. Clin J Am Soc Nephrol 2 4 (2007) 722-731
23. Reincke M., Rump L.C., Quinkler M., et al. Risk factors associated with low glomerular filtration rate in primary aldosteronsim. J Clin Endocrinol Metab 94 3 (2009) 869-875
24. Ribstein J., Du Cailar G., Fesler P., et al. Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol 16 5 (2005) 1320-1325
25. Sechi L.A., Novello M., Lapenna R., et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA 295 22 (2006) 2638-2645
26. Kimura G., Uzu T., Nakamura S., Inenaga T., and Fujii T. High sodium sensitivity and glomerular hypertension/hyperfiltration in primary aldosteronism. J Hypertens 14 12 (1996) 1463-1468
27. Dworkin L.D., Hostetter T.H., Rennke H.G., and Brenner B.M. Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest 73 5 (1984) 1448-1461
28. Uhrenholt T.R., Schjerning J., Hansen P.B., et al. Rapid inhibition of vasoconstriction in renal afferent arterioles by aldosterone. Circ Res 93 12 (2003) 1258-1266
29. Sechi L.A., Di Fabio A., Bazzocchi M., Uzzau A., and Catena C. Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab 94 4 (2009) 1191-1197
30. Rossi G.P., Sechi L.A., Giacchetti G., Ronconi V., Strazzullo P., and Funder J.W. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 19 3 (2008) 88-90
31. Hall J.E., Granger J.P., Smith Jr. M.J., and Premen A.J. Role of hemodynamics and arterial pressure in aldosterone "escape". Hypertension 6 2, pt 2 (1984) I183-I192